For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Bowel disease patients to march on PHARMAC and parliament to present 30,000+ signature petition
Bowel disease patients to march on PHARMAC and parliament to present 30,000+ signature petition

On 2 December 2020, Crohn’s and Colitis NZ will lead a march of patients, supporters and medical specialists on Pharmac and Parliament to present a petition pleading for access to ustekinumab, an urgently-needed medication for New Zealanders suffering with severe Crohn’s and Colitis, for whom
all other treatments have failed.
The march is the culmination of an intense three-month nationwide campaign to highlight the desperate need for this treatment.
Pharmac CEO Sarah Fitt and Chair Hon Steve Maharey will address the petitioners outside their headquarters, and join a three-minute silence to mark the lives of those who have suffered needlessly by not having access to medications readily available in other countries.
Act Party Leader, David Seymour, who initiated the cross-party calls for a Government review of Pharmac in the leadup to the election, will receive the petition at Parliament.
Schedule and interview opportunities
• 10.45am: Petitioners gather at Civic Square, Wellington for speeches by campaign leaders
• 11.30am: March leaves Civic Square
• 11.35am: Stop at Pharmac’s headquarters at 40 Mercer Street for 3 minute silence and
address by Pharmac chiefs
• 12.15pm: Stop at at the Cenotaph on the corner of Lambton Quay and Bowen St; patients
and doctors available for media interviews
• 1.00pm: Petition presented at Parliament
Speakers & potential interviewees
• Richard Stein, MD, FRACP, FACG, AGAF, Chair, Crohn’s & Colitis NZ
• Professor Richard Gearry MB ChB, PhD, FRACP, Professor of Medicine, University of Otago
• Belinda Brown, patient & Operations Manager, Crohn’s & Colitis NZ
• Marian O’Connor RGN, MSc, Co-Chair NZ Inflammatory Bowel Disease Nurses Group
• Hon Steve Maharey & Sarah Fitt (Pharmac CEO & Chair) at Pharmac’s headquarters on
Mercer Street
• David Seymour, Act Leader – outside Parliament
• Brooke Van Velden, Act Deputy Leader and Health Spokesperson
• Patients and their supporters